Richards Group (RIC) Q3 2024 earnings summary

Executive summary

• Q3 revenue declined 4% year-over-year, mainly due to a $3 million drop in healthcare capital sales and continued weakness in food and beverage packaging from inventory oversupply.

• Adjusted EBITDA fell by $0.3 million to 13% of sales, as higher margins from improved product mix were offset by increased administrative expenses.

• Net income decreased by $1 million, or $0.08 per unit, primarily due to a mark-to-market loss on exchangeable shares and lower Adjusted EBITDA, partially offset by reduced financial expenses.

• Free cash flow of $5 million in Q3 was used to repay $3 million in debt, invest in working capital, and settle acquisition-related payments.

• Monthly dividends of $0.11 per unit were paid, representing a 4.1% annualized yield and a 43% payout ratio for the quarter.

Financial highlights

• Q3 revenue: $97.7 million, down from $101.4 million in Q3 2023.

• Q3 net income: $6.9 million, down from $8.0 million year-over-year.

• Adjusted EBITDA for Q3: $13.1 million (13.4% of sales), down from $13.4 million (13.2%).

• Gross margin improved to 19.7% from 18.6% in Q3 2023.

• Free cash flow for Q3: $5.0 million; distributable cash flow: $8.8 million.

Outlook and guidance

• Management expects continued softness in food and beverage packaging into Q4.

• Distributable cash flow sensitivity: $0.04 million for every 1¢ U.S./Cdn. exchange movement.

• Maintenance capital to be funded by operations, with $0.8 million set aside for IT upgrades in Q4.

• Surplus distributable cash in Q4 expected to be used for further debt reduction.